Cargando…
Model for predicting age-dependent safety and immunomodulatory effects of STING ligands in non-human primates
Stimulator of interferon genes (STING) is a cytoplasmic dinucleotide sensor used as an immunomodulatory agent for cancer treatment. The efficacy of the STING ligand (STING-L) against various tumors has been evaluated in mouse models; however, its safety and efficacy in non-human primates have not be...
Autores principales: | Takahama, Shokichi, Ishige, Kazuya, Nogimori, Takuto, Yasutomi, Yasuhiro, Appay, Victor, Yamamoto, Takuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813482/ https://www.ncbi.nlm.nih.gov/pubmed/36620070 http://dx.doi.org/10.1016/j.omtm.2022.12.008 |
Ejemplares similares
-
Assessment of Fcγ receptor-dependent binding of influenza hemagglutinin vaccine-induced antibodies in a non-human primate model
por: Masuta, Yuji, et al.
Publicado: (2022) -
STING agonists activate latently infected cells and enhance SIV-specific responses ex vivo in naturally SIV controlled cynomolgus macaques
por: Yamamoto, Takuya, et al.
Publicado: (2019) -
Pattern Recognition Receptor Ligands as an Emerging Therapeutic Agent for Latent HIV-1 Infection
por: Takahama, Shokichi, et al.
Publicado: (2020) -
Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination
por: Nogimori, Takuto, et al.
Publicado: (2023) -
Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8(+) T cell quality
por: Takahama, Shokichi, et al.
Publicado: (2023)